[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR9509764A - Série androstano e pregnano para modulação alostérica de receptor de gaba - Google Patents

Série androstano e pregnano para modulação alostérica de receptor de gaba

Info

Publication number
BR9509764A
BR9509764A BR9509764A BR9509764A BR9509764A BR 9509764 A BR9509764 A BR 9509764A BR 9509764 A BR9509764 A BR 9509764A BR 9509764 A BR9509764 A BR 9509764A BR 9509764 A BR9509764 A BR 9509764A
Authority
BR
Brazil
Prior art keywords
androstane
gaba receptor
allosteric modulation
pregnane series
pregnane
Prior art date
Application number
BR9509764A
Other languages
English (en)
Inventor
Ravindra B Upasani
Hasar Tahir
Nancy C Lan
Kelvin W Gee
Michael B Bolger
Robert Purdy
Original Assignee
Cocensys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cocensys Inc filed Critical Cocensys Inc
Publication of BR9509764A publication Critical patent/BR9509764A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9509764A 1994-11-23 1995-11-22 Série androstano e pregnano para modulação alostérica de receptor de gaba BR9509764A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34692694A 1994-11-23 1994-11-23
PCT/US1995/015210 WO1996016076A1 (en) 1994-11-23 1995-11-22 Androstane and pregnane series for allosteric modulation of gaba receptor

Publications (1)

Publication Number Publication Date
BR9509764A true BR9509764A (pt) 1998-07-07

Family

ID=23361616

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9509764A BR9509764A (pt) 1994-11-23 1995-11-22 Série androstano e pregnano para modulação alostérica de receptor de gaba

Country Status (27)

Country Link
EP (1) EP0808325B1 (pt)
JP (1) JPH10509458A (pt)
KR (1) KR100394548B1 (pt)
CN (1) CN1171114A (pt)
AP (1) AP653A (pt)
AT (1) ATE198753T1 (pt)
AU (1) AU707486B2 (pt)
BR (1) BR9509764A (pt)
CA (1) CA2205919A1 (pt)
CZ (1) CZ292881B6 (pt)
DE (1) DE69519945T2 (pt)
DK (1) DK0808325T3 (pt)
ES (1) ES2155543T3 (pt)
FI (1) FI972202A (pt)
GE (1) GEP20002033B (pt)
GR (1) GR3035562T3 (pt)
HU (1) HUT77087A (pt)
IL (1) IL116108A (pt)
IS (1) IS4488A (pt)
MX (1) MX9703826A (pt)
NO (1) NO308950B1 (pt)
NZ (1) NZ298567A (pt)
PL (1) PL182898B1 (pt)
PT (1) PT808325E (pt)
RU (1) RU2176248C2 (pt)
UA (1) UA48154C2 (pt)
WO (1) WO1996016076A1 (pt)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5767117A (en) * 1994-11-18 1998-06-16 The General Hospital Corporation Method for treating vascular headaches
US6780853B1 (en) 1995-06-06 2004-08-24 Euro-Celtique S.A. Neuroactive steroids of the androstane and pregnane series
ATE284895T1 (de) * 1995-06-06 2005-01-15 Euro Celtique Sa Neuroaktive steroide der androstan- und pregnanreihe
US20010051599A1 (en) 1997-05-02 2001-12-13 Michael Z. Kagan Pregnan-3-ol-20-ones
DE69927960T2 (de) 1998-03-11 2006-07-20 Torbjörn Backström Epiallopregnanolon zur behandlung von krankheiten des cns
US8771740B2 (en) 1999-12-20 2014-07-08 Nicholas J. Kerkhof Process for producing nanoparticles by spray drying
AU778931B2 (en) 1999-12-20 2004-12-23 Nicholas J. Kerkhof Process for producing nanometer particles by fluid bed spray-drying
AR031473A1 (es) * 2000-11-20 2003-09-24 Lundbeck & Co As H Intensificadores de gaba en el tratamiento de enfermedades relacionadas con una reducida actividad neuroesteroide
WO2006012563A2 (en) * 2004-07-23 2006-02-02 The Regents Of The University Of California Method for the treatment and diagnosis of certain psychiatric disorders related to the menstrual cycle
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド アンジオテンシン調節による神経新生
ES2607852T3 (es) 2006-11-21 2017-04-04 Umecrine Ab El uso de esteroides de pregnano y androstano para la fabricación de una composición farmacéutica para el tratamiento de trastornos del SNC
CN103880909A (zh) * 2008-05-20 2014-06-25 梅克芳股份公司 甾族化合物
CN103819525A (zh) * 2008-05-20 2014-05-28 梅克芳股份公司 甾族化合物
CN101585862B (zh) * 2008-05-20 2014-12-17 梅克芳股份公司 甾族化合物
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2011019821A2 (en) * 2009-08-13 2011-02-17 Marinus Pharmaceuticals, Inc. METHOD FOR MAKING 3α-HYDROXY, 3β- METHYL-5α-PREGNAN-20-ONE (GANAXOLONE)
DK2523666T3 (en) 2010-01-14 2016-04-04 Asarina Pharma Ab A pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties
US20130245253A1 (en) * 2010-03-26 2013-09-19 Department Of Veterans Affairs Conjugated Neuroactive Steroid Compositions And Methods Of Use
WO2013019711A2 (en) * 2011-07-29 2013-02-07 The Regents Of The University Of California NOVEL 17β-HETEROARYL-SUBSTITUTED STEROIDS AS MODULATORS OF GABAA RECEPTORS
US20150158903A1 (en) * 2011-09-08 2015-06-11 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US10478505B2 (en) 2011-09-23 2019-11-19 The Regents Of The University Of California Edible oils to enhance delivery of orally administered steroids
PT2766380T (pt) * 2011-10-14 2019-07-29 Sage Therapeutics Inc Compostos de 19-nor pregnano 3,3-dissubstituídos, composições e seus usos
ES2758446T3 (es) 2012-01-23 2020-05-05 Sage Therapeutics Inc Formulaciones de esteroides neuroactivos que comprenden un complejo de alopregnanolona y sulfobutil éter beta-ciclodextrina
CN104736159A (zh) 2012-08-21 2015-06-24 萨奇治疗股份有限公司 治疗癫痫或癫痫持续状态的方法
DK2925327T3 (da) 2012-11-30 2024-03-25 Univ California Allopregnanolon til behandling, reduktion eller lindring af symptomer på fødselsdepression
LT3461834T (lt) 2013-03-13 2021-10-25 Sage Therapeutics, Inc. Neuroaktyvūs steroidai
CN112110976B (zh) 2013-04-17 2023-08-29 萨奇治疗股份有限公司 刺激神经活性的19-去甲类固醇及其使用方法
WO2014169831A1 (en) * 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
WO2014169836A1 (en) * 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
LT2986623T (lt) 2013-04-17 2019-02-25 Sage Therapeutics, Inc. 19-nor c3,3-dipakeistieji c21-n-pirazolilo steroidai ir jų panaudojimo būdai
EP3021852B1 (en) 2013-07-19 2021-01-27 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
SI3488852T1 (sl) 2013-08-23 2021-07-30 Sage Therapeutics, Inc. Nevroaktivni steroidi, sestavki in uporabe le-teh
EP3157528B1 (en) 2014-06-18 2023-09-13 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
EP3188734A4 (en) 2014-09-02 2018-01-10 The Texas A&M University System Method of treating organophosphate intoxication
JOP20200195A1 (ar) * 2014-09-08 2017-06-16 Sage Therapeutics Inc سترويدات وتركيبات نشطة عصبياً، واستخداماتها
DK3206493T3 (da) 2014-10-16 2020-08-10 Sage Therapeutics Inc Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
US10577390B2 (en) 2014-10-16 2020-03-03 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
PL3224269T3 (pl) 2014-11-27 2020-08-24 Sage Therapeutics, Inc. Kompozycje i sposoby leczenia zaburzeń OUN
DK3250210T3 (da) 2015-01-26 2021-03-08 Sage Therapeutics Inc Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
ES2935476T3 (es) 2015-02-20 2023-03-07 Sage Therapeutics Inc Esteroides neuroactivos, composiciones y usos de los mismos
US11117924B2 (en) 2015-07-06 2021-09-14 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
TWI798173B (zh) 2016-03-08 2023-04-11 美商賽吉醫療公司 神經活性類固醇，其組合物及用途
RU2754130C2 (ru) 2016-04-01 2021-08-27 Сейдж Терапьютикс, Инк. Оксистеролы и способы их применения
WO2017193046A1 (en) 2016-05-06 2017-11-09 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
DK3481844T3 (da) 2016-07-11 2024-07-22 Sage Therapeutics Inc C7, C12 og C16 substituerede neuroaktive steroider og disses fremgangsmåder til anvendelse
EP3481845B1 (en) 2016-07-11 2023-09-13 Sage Therapeutics, Inc. C17, c20, and c21 substituted neuroactive steroids and their methods of use
US11149056B2 (en) 2016-09-30 2021-10-19 Sage Therapeutics, Inc. C7 substituted oxysterols and methods of use thereof
NZ752732A (en) 2016-10-18 2024-08-30 Sage Therapeutics Inc Oxysterols and methods of use thereof
WO2019140272A1 (en) * 2018-01-12 2019-07-18 Sage Therapeutics, Inc. Aza-, oxa and thia-pregnan-20-one-3.alpha.-ol compounds for use in treating cns disorders
EP3784682A1 (en) * 2018-04-23 2021-03-03 The Texas A&M University System Neurosteroid compounds and methods for their preparation and use in treating central nervous system disorders
BR112021009428A2 (pt) 2018-10-12 2021-08-31 Sage Therapeutics, Inc. Esteroides neuroativos substituídos na posição 10 por um grupo cíclico para uso no tratamento de distúrbios do cns
JP7539378B2 (ja) 2018-12-05 2024-08-23 セージ セラピューティクス， インコーポレイテッド 神経刺激性ステロイド及びその使用方法
CN111410673A (zh) * 2019-01-08 2020-07-14 成都康弘药业集团股份有限公司 甾体类化合物、用途及其制备方法
JOP20210293A1 (ar) 2019-05-31 2023-01-30 Sage Therapeutics Inc ستيرويدات ذات فعالية عصبية وتركيبات منها
BR112021026445A2 (pt) * 2019-06-27 2022-03-08 Sage Therapeutics Inc Composições e métodos para tratar distúrbios de cns
EP4121438A2 (en) * 2020-03-18 2023-01-25 Sage Therapeutics, Inc. Neuroactive steroids and their methods of use
EP4387626A1 (en) * 2021-08-20 2024-06-26 University of Mississippi Allopregnanolone analogues for hiv viremia and neurotoxicity protection
WO2023060067A1 (en) 2021-10-04 2023-04-13 Marinus Pharmaceuticals, Inc. Amorphous solid dispersion ganaxolone formulation
CN117801047A (zh) * 2023-01-19 2024-04-02 北京华睿鼎信科技有限公司 神经甾体衍生物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953429A (en) * 1970-12-17 1976-04-27 Glaxo Laboratories Limited Anaesthetic steroids of the androstance and pregnane series
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
US5120723A (en) * 1987-08-25 1992-06-09 University Of Southern California Method, compositions, and compounds for modulating brain excitability
EP0603312A4 (en) * 1991-09-13 1995-06-07 Cocensys Inc NEW GABA A RECEPTOR WITH STEROID BINDING POINTS.
US5371077A (en) * 1992-08-03 1994-12-06 William Marsh Rice University Side chain derivatized 15-oxygenated sterols, methods of using them and a process for preparing them
DE69435286D1 (de) * 1993-05-24 2010-05-20 Purdue Pharma Ltd Verfahren und zusammensetzungen zum hervorrufen von schlaf

Also Published As

Publication number Publication date
GR3035562T3 (en) 2001-06-29
AU707486B2 (en) 1999-07-08
CZ292881B6 (cs) 2003-12-17
JPH10509458A (ja) 1998-09-14
PL182898B1 (pl) 2002-03-29
WO1996016076A1 (en) 1996-05-30
ES2155543T3 (es) 2001-05-16
IL116108A0 (en) 1996-01-31
RU2176248C2 (ru) 2001-11-27
MX9703826A (es) 1998-02-28
DE69519945D1 (de) 2001-02-22
AP9700998A0 (en) 1997-07-31
IL116108A (en) 2002-08-14
EP0808325A4 (pt) 1997-12-17
FI972202A (fi) 1997-07-17
UA48154C2 (uk) 2002-08-15
NO972320D0 (no) 1997-05-21
IS4488A (is) 1997-05-23
NZ298567A (en) 2000-01-28
PT808325E (pt) 2001-06-29
HUT77087A (hu) 1998-03-02
DE69519945T2 (de) 2001-06-07
EP0808325B1 (en) 2001-01-17
AU4408596A (en) 1996-06-17
AP653A (en) 1998-07-21
KR100394548B1 (ko) 2004-02-05
DK0808325T3 (da) 2001-01-29
CN1171114A (zh) 1998-01-21
EP0808325A1 (en) 1997-11-26
NO972320L (no) 1997-07-23
ATE198753T1 (de) 2001-02-15
NO308950B1 (no) 2000-11-20
PL320416A1 (en) 1997-09-29
GEP20002033B (en) 2000-04-10
CA2205919A1 (en) 1996-05-30
FI972202A0 (fi) 1997-05-23
CZ155397A3 (cs) 1998-03-18

Similar Documents

Publication Publication Date Title
BR9509764A (pt) Série androstano e pregnano para modulação alostérica de receptor de gaba
BR9609738B1 (pt) dispositivo estabilizado de emplasto para aplicação de uma droga esteróide.
DE69835020D1 (de) Plasmabrenner und verwendungsverfahren dieses plasmabrenners
AU6963898A (en) Surgical apparatus for determining ligament and tendon tension
AU6684698A (en) Anterior cruciate ligament tensioning device and method for its use
HUP9901138A3 (en) Neuroactive steroids of the androstane and pregnane series
DE69625660D1 (de) Spendevorrichtung für chirurgische befestigungsplättchen
BR9510537A (pt) Aparelho para controlar um sistema de transmissão de corrente alternada incluindo uma linha de transmissão transportando corrente alternada em uma voltagem de linha de transmissão selecionada e frequência fundamental
DE69840316D1 (de) Befestigungsmittel und dieses enthaltendens Steuerapparat für Flüssigkeiten
DE69826485D1 (de) Selbstverriegelungs- und selbstentriegelungsvorrichtung für auswechselbare sitze
DE69805438D1 (de) Misch- und ladeöffnung zur medizinischen behandlung
DE69635710D1 (de) Eingabegerät für bilderzeugungsverfahren und -gerät
DE69637236D1 (de) Bilderzeugungseinheit für ein Bilderzeugungsgerät und Tonertransportvorrichtung
DE69830644D1 (de) Elektrophotographisches lichtempfindliches Element, elektrophotographischer Apparat und elektrophotographisches Verfahren
DE69623233D1 (de) Fixierrolle und Silikongel dafür
DE69621440D1 (de) Teller für pizza und dazu gehörendes verfahren
BR9706801A (pt) Aparelho e conjunto de sujeição com roletes para caixas cõnicas de quatro lados
BR9801408A (pt) Aparelho para fixação de tubo de distribuição de exaustão e método para fabricação do mesmo
DE69829616D1 (de) Toner und Entwicklerzusammensetzungen mit Kompatibilisierungsmitteln
DE69316295D1 (de) Reinigungseinrichtung für ein elektrophotografisches Gerät und ein diese Reinigungseinrichtung verwendendes elektrophotografisches Gerät
DE69511223D1 (de) Elektrophotographisches lichtempfindliches Element und elektrophotographisches Gerät
BR9505760A (pt) Dispositivo de fornecimento de oxidante e método para efetuar combustão
NO972655D0 (no) Emulsjonsdrivstoff og apparat til forbrenning av samme
BR9608272A (pt) Metodo e dispositivo para liberar placas catodicas
DE69417705D1 (de) Ladesystem und elektrophotographischer Apparat

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]